541 related articles for article (PubMed ID: 25624441)
21. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
[TBL] [Abstract][Full Text] [Related]
22. Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia.
Singh M; Bhatia P; Khera S; Trehan A
Leuk Res; 2017 Nov; 62():17-22. PubMed ID: 28963908
[TBL] [Abstract][Full Text] [Related]
23. Effects of
Mao X; Yin R; Sun G; Zhou Y; Yang C; Fang C; Wu Y; Cui T; Liu L; Gan J; Tian X
Front Pediatr; 2021; 9():719803. PubMed ID: 34660484
[No Abstract] [Full Text] [Related]
24. Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.
Sabirova Z; Mahnoor S; Lasfar D; Gagné V; Théorêt Y; Leclerc JM; Laverdière C; Sinnett D; Tran TH; Krajinovic M
Pharmacogenet Genomics; 2024 Jul; 34(5):170-173. PubMed ID: 38682355
[TBL] [Abstract][Full Text] [Related]
25.
Moradveisi B; Muwakkit S; Zamani F; Ghaderi E; Mohammadi E; Zgheib NK
Front Pharmacol; 2019; 10():916. PubMed ID: 31507415
[No Abstract] [Full Text] [Related]
26. Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT.
Park Y; Kim H; Seo H; Choi JY; Ma Y; Yun S; Min BJ; Seo ME; Yoo KH; Kang HJ; Im HJ; Kim JH
J Transl Med; 2020 Jul; 18(1):265. PubMed ID: 32611418
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
Moriyama T; Yang W; Smith C; Pui CH; Evans WE; Relling MV; Bhatia S; Yang JJ
Pharmacogenet Genomics; 2022 Feb; 32(2):60-66. PubMed ID: 34412101
[TBL] [Abstract][Full Text] [Related]
28. [Association between polymorphism of NUDT15 gene and hepatotoxicity induced by 6-MP in children with acute lymphoblastic leukemia].
Wang X; Wang W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1258-1261. PubMed ID: 34839520
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetic determinants of thiopurines in an Indian cohort.
Naushad SM; Janaki Ramaiah M; Kutala VK; Hussain T; Alrokayan SA
Pharmacol Rep; 2021 Feb; 73(1):278-287. PubMed ID: 32935219
[TBL] [Abstract][Full Text] [Related]
30. Determination of NUDT15 variants by targeted sequencing can identify compound heterozygosity in pediatric acute lymphoblastic leukemia patients.
Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Raghav L; Chang HH; Wu KH; Chou SW; Ni YL; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2020 Sep; 10(1):14400. PubMed ID: 32873882
[TBL] [Abstract][Full Text] [Related]
31. Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance.
Yoshida M; Brown SA; Moriyama T; Nishii R; Tsujimoto SI; Yamada Y; Yoshida K; Shirai R; Osumi T; Utano T; Fukano R; Kudo K; Sakaguchi K; Arakawa Y; Koh K; Sekiguchi M; Sekimizu M; Miyamura T; Ishida H; Inukai T; Tomizawa D; Kiyokawa N; Kato M; Yang JJ
Br J Haematol; 2022 Oct; 199(2):270-276. PubMed ID: 35905175
[TBL] [Abstract][Full Text] [Related]
32. [Significance of NUDT15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia].
He J; Liu L
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jan; 21(1):100-104. PubMed ID: 30675872
[TBL] [Abstract][Full Text] [Related]
33. The influence of
Nguyen ML; Hoang AV; Duong BT; Phung NTN
HGG Adv; 2023 Apr; 4(2):100183. PubMed ID: 36873097
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.
Tanaka Y; Manabe A; Fukushima H; Suzuki R; Nakadate H; Kondoh K; Nakamura K; Koh K; Fukushima T; Tsuchida M; Koike K; Kiyokawa N; Noguchi E; Sumazaki R; Komiyama T
Pharmacogenomics J; 2015 Aug; 15(4):380-4. PubMed ID: 25403995
[TBL] [Abstract][Full Text] [Related]
35. Screening for mercaptopurine intolerance in ALL - target the genes or their product?
Barrett J
Br J Haematol; 2022 Oct; 199(2):173-174. PubMed ID: 36120820
[TBL] [Abstract][Full Text] [Related]
36. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.
Moriyama T; Nishii R; Perez-Andreu V; Yang W; Klussmann FA; Zhao X; Lin TN; Hoshitsuki K; Nersting J; Kihira K; Hofmann U; Komada Y; Kato M; McCorkle R; Li L; Koh K; Najera CR; Kham SK; Isobe T; Chen Z; Chiew EK; Bhojwani D; Jeffries C; Lu Y; Schwab M; Inaba H; Pui CH; Relling MV; Manabe A; Hori H; Schmiegelow K; Yeoh AE; Evans WE; Yang JJ
Nat Genet; 2016 Apr; 48(4):367-73. PubMed ID: 26878724
[TBL] [Abstract][Full Text] [Related]
37. Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.
Ma X; Zheng J; Jin M; Li W; Gao C; Zhang D; Chen Y; Li X; Xie J
Int J Clin Exp Pathol; 2014; 7(7):4552-6. PubMed ID: 25120852
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
Khera S; Trehan A; Bhatia P; Singh M; Bansal D; Varma N
Cancer Chemother Pharmacol; 2019 Feb; 83(2):341-348. PubMed ID: 30474703
[TBL] [Abstract][Full Text] [Related]
39. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia.
Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Cheng CN; Chang HH; Chou SW; Su MY; Ni YL; Xu PY; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2023 Jan; 13(1):490. PubMed ID: 36627439
[TBL] [Abstract][Full Text] [Related]
40. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
